SC 13G
PUMA BIOTECHNOLOGY, INC.
- Company
- PUMA BIOTECHNOLOGY, INC.
- Filed
- February 12, 2016
- Accession Number
- 0001072613-16-000594
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →